Open Access Publications
Permanent URI for this collection
Open access publications by faculty, postdocs, and graduate students in the Department of Chemical and Biomolecular Engineering
Browse
Browsing Open Access Publications by Author "Akkiraju, H."
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Development of Physiologically Based Pharmacokinetic Model (PBPK) of BMP2 in Mice(OMICS Group, 2013) Utturkar, A.; Paul, B.; Akkiraju, H.; Bonor, J.; Dhurjati, Prasad; Nohe, Anja; Utturkar A, Paul B, Akkiraju H, Bonor J, Dhurjati P, Nohe A; Utturkar, A.; Paul, B.; Akkiraju, H.; Bonor, J.; Dhurjati, Prasad; Nohe, AnjaBone Morphogenetic protein 2 holds great promise for potential applications in the clinic. It is a potent growth factor for the use in the cervical spine surgery (FDA approved 2002) and has been marketed as “Infuse” for treating open tibial shaft fractures (FDA approved 2004). However, its use is limited by several significant side effects that maybe due to its potency and effect on different stem cell populations in the spine. BMP2 is expressed throughout the human body in several tissues and at a very high concentration in the blood. BMP receptors, especially BMP receptor type Ia, is ubiquitously expressed in most tissues. Currently, it is difficult to determine how BMP2 is physiologically distributed in mice or humans and no quantitative models are available. A Physiologically-Based Pharmaco-Kinetic (PBPK) model has been developed to determine steady-state distribution of BMP2 in mice. The multi-compartmental PBPK model represents relevant organ/tissues with physiological accuracy. The organs/tissue compartments chosen were brain, lung, heart, liver, pancreas, kidney, uterus, bone and fat. A blood compartment maintained connectivity among the various organs. Four processes characterized the change in the concentration of the protein in every compartment: blood flow in, blood flow out, protein turnover and receptor binding in the organ. The unique aspects of the model are the determination of elimination using receptor kinetics and generation using protein turnover. The model also predicts steady state concentrations of BMP2 in tissues in mice and may be used for possible scale-up of dosage regimens in humans.